Hosted on MSN1mon
Large-scale breast cancer screening trial achieves enrollment goal, paving the way for precision approach to screeningThe Tomosynthesis Mammographic Imaging Screening Trial (TMIST) has reached its enrollment goal of 108,508 women, as announced today by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN). The study ...
According to the World Health Organization, 1 in 12 women worldwide are diagnosed with breast cancer in their lifetime. Breast cancer remains one of the most prevalent, life-threatening diseases ...
Biomediq’s breast cancer risk analysis technology is centred around a mammographic texture risk biomarker model that recognises tissue heterogeneity, typically dubbed mammographic texture ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results